3rd Quarter - Report

BIOCOM for BIOCOM

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$45,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Report (this page) Nov 17, 2020 $45,000 Replaced
3rd Quarter - Amendment Nov 17, 2020 $45,000 Yes

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Advocated for additional funding for NIH and BARDA in FY2021 appropriations and coronavirus supplemental legislation.

LobbyistCovered position, as disclosed
LAURE FABREGA CLARK —

Contacted: Treasury, Dept of; SENATE; Small Business Administration (SBA); HOUSE OF REPRESENTATIVES

Labor Issues/Antitrust/Workplace LBR

Advocated for targeted and temporary liability protections for life science organizations

LobbyistCovered position, as disclosed
LAURE FABREGA CLARK —

Contacted: Small Business Administration (SBA); Treasury, Dept of; HOUSE OF REPRESENTATIVES; SENATE

Copyright/Patent/Trademark CPT

Expressed support for the Bayh-Dole Act, as part of the law's 40th anniversary campaign

LobbyistCovered position, as disclosed
LAURE FABREGA CLARK —

Contacted: Small Business Administration (SBA); Treasury, Dept of; SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Sent information to House and Senate staff about the life science's industry response to covid-19. Sent comments to the HELP Committee re "Preparing for the Next Pandemic" white paper. Expressed support for the coverage of home infusion of Medicare Part B drugs during the covid-19 pandemic. Advocated for the exemption of life science research facilities from stay-at-home orders Expressed position on and challenges with domesticating the US drug supply chain Expressed support for expanding telehealth services Expressed support for policies that encourage the use and development of novel antibiotics to fight anti-microbial resistance (AMR)

LobbyistCovered position, as disclosed
LAURE FABREGA CLARK —

Contacted: Small Business Administration (SBA); SENATE; Treasury, Dept of; HOUSE OF REPRESENTATIVES

Small Business SMB

Advocated for additional funding for the Paycheck Protection Program (PPP), which had run out of funding Urged the US Treasury Department and SBA to clarify that small businesses with equity investors will be eligible for the small business loan program created by the CARES Act.

LobbyistCovered position, as disclosed
LAURE FABREGA CLARK —

Contacted: SENATE; Small Business Administration (SBA); HOUSE OF REPRESENTATIVES; Treasury, Dept of

Immigration IMM

Expressed concerns with proposals that would restrict visas for international students, researchers and faculty as the country reopens

LobbyistCovered position, as disclosed
LAURE FABREGA CLARK —

Contacted: HOUSE OF REPRESENTATIVES; Small Business Administration (SBA); SENATE; Treasury, Dept of

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.